BlackRock Investment Management, LLC - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 152 filers reported holding ARRAY BIOPHARMA INC in Q2 2015. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q4 2016$5,937,000
+47.7%
675,469
+13.4%
0.01%
+40.0%
Q3 2016$4,019,000
+90.7%
595,435
+0.6%
0.01%
+66.7%
Q2 2016$2,107,000
+46.5%
591,989
+21.4%
0.00%
+50.0%
Q1 2016$1,438,000
-29.0%
487,467
+1.6%
0.00%
-33.3%
Q4 2015$2,024,000
-7.5%
479,611
-0.0%
0.00%0.0%
Q3 2015$2,187,000
-37.7%
479,668
-1.5%
0.00%
-25.0%
Q2 2015$3,512,000
+13.9%
487,155
+16.5%
0.00%0.0%
Q1 2015$3,083,000
+75.3%
418,251
+12.5%
0.00%
+100.0%
Q4 2014$1,759,000
+30.0%
371,942
-1.9%
0.00%0.0%
Q3 2014$1,353,000
-21.2%
379,016
+0.7%
0.00%0.0%
Q2 2014$1,717,000
+6.5%
376,494
+9.7%
0.00%0.0%
Q1 2014$1,612,000
-4.7%
343,080
+1.6%
0.00%
-33.3%
Q4 2013$1,692,000
-17.8%
337,804
+2.1%
0.00%0.0%
Q3 2013$2,059,000
+45.9%
331,004
+6.5%
0.00%0.0%
Q2 2013$1,411,000310,6910.00%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q2 2015
NameSharesValueWeighting ↓
Redmile Group, LLC 16,618,776$146,079,00012.59%
BVF INC/IL 4,986,186$43,829,0008.81%
First Light Asset Management, LLC 1,000,361$8,793,0003.86%
Crosspoint Capital Strategies, LLC 463,005$4,070,0003.62%
Consonance Capital Management LP 2,723,471$23,912,0002.63%
KOPP INVESTMENT ADVISORS LLC 219,926$1,933,0002.04%
SPHERA FUNDS MANAGEMENT LTD. 900,000$7,911,0002.00%
Orbimed Advisors 16,088,800$141,421,0001.80%
Cormorant Asset Management, LP 1,150,000$10,109,0001.36%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 2,073,680$18,227,0001.26%
View complete list of ARRAY BIOPHARMA INC shareholders